Climb Bio Website
1 known investors
Climb Bio develops monoclonal antibody therapies for immune-mediated diseases, advancing clinical-stage candidates such as budoprutug for conditions including immune thrombocytopenia. Its investigational therapies target patients with limited treatment options.
Founders & leadership
AB
Aoife Brennan, MB, ChBPresident and Chief Executive Officer
PW
Perrin Wilson, PhDChief Business Officer
SA
Susan Altschuller, PhD, MBAChief Financial Officer
EC
Edgar Charles, MDChief Medical Officer
AJ
Ashley JonesSenior Vice President, People & Workforce Strategy
AV
Adam Villa, MBA, MSSenior Vice President, Technical Operations
CA
Chandra Adams, JDSenior Vice President, General Counsel
Investors Β· 1
Frequently asked questions
- What does Climb Bio Website do?
- Climb Bio develops monoclonal antibody therapies for immune-mediated diseases, advancing clinical-stage candidates such as budoprutug for conditions including immune thrombocytopenia. Its investigational therapies target patients with limited treatment options.
- Who are Climb Bio Website's investors?
- Climb Bio Website's investors include LifeArc Ventures.